Copyright
©The Author(s) 2019.
World J Clin Cases. Dec 26, 2019; 7(24): 4377-4383
Published online Dec 26, 2019. doi: 10.12998/wjcc.v7.i24.4377
Published online Dec 26, 2019. doi: 10.12998/wjcc.v7.i24.4377
Table 1 The timeline of treatment
| Time | Symptoms | Diagnoses | Treatments |
| 2008 | Canker sores | Undifferentiated connective tissue disease | Low doses of prednisone: 5 mg |
| White blood cell count: 1.8 × 109/L | |||
| ANA: 1:320(+) | |||
| Blood complements: Normal | |||
| Serum creatinine: 66 µmol/L | |||
| 2016 | Facial erythema | Undifferentiated connective tissue disease | Hydroxychloroquine; Prednisone |
| Decreased blood complements | |||
| April 2018 | Weight loss | Undifferentiated connective tissue disease; Hydroxychloroquine -induced renal phospholipidosis | Withdrawal of hydroxychloroquine; Prednisone |
| Weakness | |||
| White blood count: 2.7-4.7 × 109/L | |||
| Urine erythrocytes: 28/µL | |||
| Serum creatinine: 58 µmol/L | |||
| 24-h urinary protein, quantitative: 1120 mg | |||
| ANA: 1:80(+) | |||
| Complement C3: 0.58 g/L | |||
| Complement C4: 0.09 g/L | |||
| Renal biopsy: Renal phospholipidosis | |||
| Mutation of GLA gene: Negative |
- Citation: Wu SZ, Liang X, Geng J, Zhang MB, Xie N, Su XY. Hydroxychloroquine-induced renal phospholipidosis resembling Fabry disease in undifferentiated connective tissue disease: A case report. World J Clin Cases 2019; 7(24): 4377-4383
- URL: https://www.wjgnet.com/2307-8960/full/v7/i24/4377.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v7.i24.4377